GlassScriptPhysician profile
Keith D Newman
NPI 1912953050
$3,137.25
in general payments reported to CMS, 2019-2025
36 companies · $24.63 in 2025
The $24.63 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $642 · 2020: $149 · 2021: $157 · 2022: $767 · 2023: $858 · 2024: $539 · 2025: $24.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $368.84 | 2019-2024 | Myrbetriq |
| Myriad Genetic Laboratories, INC. | $251.69 | 2023-2024 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $228.37 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $207.78 | 2019-2024 | Provenge |
| Janssen Biotech, INC. | $202.45 | 2019-2025 | Erleada, Akeega |
| Pfizer INC. | $188.21 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $152.99 | 2023-2024 | Orgovyx, Gemtesa |
| Olympus America INC. | $146.97 | 2019-2023 | Itind System |
| Boston Scientific Corporation | $145.95 | 2019-2023 | Rezum Generator |
| Endo Pharmaceuticals INC. | $143.00 | 2019-2024 | Xiaflex, Aveed |
| Blue Earth Diagnostics | $103.61 | 2022-2024 | |
| Urovant Sciences INC | $98.22 | 2022 | |
| Myovant Sciences INC. | $97.90 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $86.96 | 2019-2024 | Adstiladrin |
| Innovation Technologies INC | $70.76 | 2022-2024 | Irrisept |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $67.96 | 2022-2023 | Pylarify |
| Axonics, INC. | $47.49 | 2022 | |
| Endo USA, INC. | $42.79 | 2024 | Xiaflex |
| Antares Pharma, INC. | $42.09 | 2020-2022 | |
| Abbvie INC. | $41.88 | 2023 | |
| Novartis Pharmaceuticals Corporation | $40.77 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $38.53 | 2021-2024 | Lynparza |
| Urogen Pharma, INC. | $36.37 | 2022-2023 | Jelmyto |
| Allergan, INC. | $34.58 | 2020-2021 | |
| Baxter Healthcare | $33.37 | 2019 | |
| Coloplast Corp | $26.85 | 2019 | |
| Neotract INC. | $25.56 | 2019-2020 | |
| Tolmar, INC. | $25.53 | 2023 | |
| Ethicon US, LLC | $23.11 | 2023 | Vistaseal, Surgiflo Hemostatic Matrix |
| Travere Therapeutics, INC. | $21.12 | 2019 | |
| Procept Biorobotics Corporation | $20.88 | 2024 | Aquabeam System |
| Telix Pharmaceuticals | $19.94 | 2023 | Illuccix |
| Verity Pharmaceuticals INC. | $16.96 | 2024 | Trelstar |
| Karl Storz Endoscopy-America | $13.53 | 2019 | |
| Teleflex LLC | $12.40 | 2022 | |
| Metuchen Pharmaceuticals | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.